TD Cowen analyst Yaron Werber downgraded Immuneering Corporation (NASDAQ: IMRX) from Outperform to Market Perform.The analyst comments "IMM-1-104 failed to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE